Parallel importers play an essential role in cost containment in the health care system. However, they are particularly challenged by the implementation of the EU Directive 2011/62/EU and the Delegated Act to prevent counterfeit medicines. There is no other type of stakeholder in the pharmaceutical industry where the critical business processes are more affected. In addition to the regulatory requirements that have already had to be met, the following processes must now be implemented.
In addition to appropriate hardware, such as cameras for scanning and printers for applying the variable data, these process steps require a system that supports the individual steps. SecIdent Pharma does this in an ideal way and is successfully used by many parallel importers.
Above all, a reliable communication infrastructure is required that enables communication with the respective NMVS via the EU hub of the European Medicines Verification Organization (EMVO). BrainGate is not only fully integrated with SecIdent, but can also be integrated into your own processes and procedures thanks to its open interfaces.